Engineering Bacteria for Vaccine Delivery
News May 18, 2015
Infections by the Mycosplama group of bacteria cause serious health problems such as pneumonia and infections in livestock cause large financial losses for farmers.
The bacteria are the smallest free-living organisms that lack cell walls, something which makes them resistant to common antibiotics like penicillin. There are currently no vaccines available for humans and pets, or for farm animals apart from pigs and poultry.
This project is important because it’s a real-world application of synthetic biology that has huge potential for tackling a serious health problem in humans and animals, says Dr Mark Isalan.
Now, biologists in the MycoSynVac project propose to engineer the bacteria Mycoplasma pneumonia, removing its ability to cause disease, to create a vaccine ‘chassis’. This would be used to carry selected antigens for fighting different Mycoplasma pathogens. This should create an effective vaccine, using a live but weakened version of the infectious bacteria to prepare the immune system for any potential attacks.
The researchers believe that the vaccine chassis would be adaptable and easier to produce than traditional vaccines for this group of diseases. Two vaccines currently exist for Mycoplasma diseases in pigs and poultry, but they require a complex growth medium, making production slow and prone to errors.
The scientists aim to improve the new Mycoplasma chassis using bioengineering techniques, so that it grows faster in a simpler medium, reducing inefficiency and improving production. Mycoplasma traditionally grows very slowly, but the researchers intend to modify it to reproduce more like faster-growing bacterial species.
Dr Mark Isalan, a reader in gene network engineering from the Department of Life Sciences and Imperial College London, is a partner in the project. He said: “This project is important because it’s a real-world application of synthetic biology that has huge potential for tackling a serious health problem in humans and animals.
"Many projects work on ‘toy systems’ designed to further our understanding of how far we can take biological engineering, but this project has a clear goal. We are applying the lessons we've learned in toy systems to the real world.”
“We have been working for a long time to deeply understand Mycoplasma pneumoniae and now, we are ready to take a step forward and use this knowledge for the benefit of society,” adds Maria Lluch, staff scientist at the Centre for Genomic Regulation in Spain and scientific co-coordinator of MycoSynVac.
The group hope the chassis technology could also be used to develop other vaccines, as well as be applied in other medical areas, such as therapies for infectious lung diseases.
The Smoke Screen - Sensor Arms Race is OnNews
The military uses smoke grenades in dangerous situations to provide cover for people and tanks on the move. But increasingly, sensors can now go beyond the visible range into the infrared (IR) region of the spectrum. Today, researchers report developing a new kind of smoke that obscures both visible and IR detection.READ MORE
Grape Waste Goes From Landfill to LipstickNews
The world drinks a lot of wine, and that means a lot of grapes are consumed every year. But not every part of the grape ends up in the bottle. Seeds, stalks and skins are typically discarded in landfills as waste. But now, researchers say they have found some useful commercial applications, such as prolonging the shelf life of fatty foods, for these wine leftovers.READ MORE
Small Tweak Makes Progress Towards Improved Flu TreatmentNews
Researchers report that a tweak to a small-molecule drug shows promise for future production of new antiviral therapies that could help patients, regardless of the strain with which they are infected.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018